Brazil Oral Solid Dosage Contract Manufacturing Market Size & Outlook
The oral solid dosage contract manufacturing market in Brazil is expected to reach a projected revenue of US$ 2,584.5 million by 2030. A compound annual growth rate of 5.6% is expected of Brazil oral solid dosage contract manufacturing market from 2025 to 2030.
HC Outsourcing
CMO/CDMO
Oral Solid Dosage Contract Manufacturing Market Outlook
Brazil oral solid dosage contract manufacturing market highlights
The Brazil oral solid dosage contract manufacturing market generated a revenue of USD 1,863.7 million in 2024 and is expected to reach USD 2,584.5 million by 2030.
The Brazil market is expected to grow at a CAGR of 5.6% from 2025 to 2030.
In terms of segment, tablets was the largest revenue generating product in 2024.
Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
Oral solid dosage contract manufacturing market data book summary
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Brazil oral solid dosage contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
Brazil is the fastest growing regional market in Latin America and is projected to reach USD 2,584.5 million by 2030.
The robust growth & development in biologics and the rising pharmaceutical market are expected to boost oral solid dosage contract manufacturing. Moreover, the demand for oral solid dosage contract manufacturing in the country is growing, as consumers are increasingly seeking oral solid dosage products due to the growing burden of diseases.
In addition, the country’s demand for oral solid dosage contract manufacturing can be attributed to the fact that investors continue to invest in the growth of pharmaceutical manufacturing facilities in Brazil coupled with untapped opportunities present in the country.
Brazil Oral Solid Dosage Contract Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oral Solid Dosage Contract Manufacturing Market Outlook will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 33.6% in 2024.
Horizon Databook has segmented the Brazil oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
The robust growth & development in biologics and the rising pharmaceutical market are expected to boost oral solid dosage contract manufacturing. Moreover, the demand for oral solid dosage contract manufacturing in the country is growing, as consumers are increasingly seeking oral solid dosage products due to the growing burden of diseases.
In addition, the country’s demand for oral solid dosage contract manufacturing can be attributed to the fact that investors continue to invest in the growth of pharmaceutical manufacturing facilities in Brazil coupled with untapped opportunities present in the country.
Brazil Oral Solid Dosage Contract Manufacturing Market Product Outlook (Revenue, USD Million , 2018-2030)
Tablets
Capsules
Powders
Granules
Others
Brazil Oral Solid Dosage Contract Manufacturing Market Mechanism Outlook (Revenue, USD Million , 2018-2030)
Immediate Release
Delayed Release
Controlled Release
Brazil Oral Solid Dosage Contract Manufacturing Market End User Outlook (Revenue, USD Million , 2018-2030)
Large Size Companies
Medium & Small Size Companies
Others
Reasons to subscribe to Oral Solid Dosage Contract Manufacturing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oral Solid Dosage Contract Manufacturing Market Outlook databook
Our clientele includes a mix of Oral Solid Dosage Contract Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil Oral Solid Dosage Contract Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Brazil Oral Solid Dosage Contract Manufacturing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Brazil Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (US$M)